Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Xometry (XMTR) Cash & Equivalents (2020 - 2025)

Xometry has reported Cash & Equivalents over the past 6 years, most recently at $15.0 million for Q4 2025.

  • Quarterly results put Cash & Equivalents at $15.0 million for Q4 2025, down 32.55% from a year ago — trailing twelve months through Dec 2025 was $15.0 million (down 32.55% YoY), and the annual figure for FY2025 was $15.0 million, down 32.55%.
  • Cash & Equivalents for Q4 2025 was $15.0 million at Xometry, down from $20.8 million in the prior quarter.
  • Over the last five years, Cash & Equivalents for XMTR hit a ceiling of $86.3 million in Q4 2021 and a floor of $15.0 million in Q4 2025.
  • Median Cash & Equivalents over the past 5 years was $39.7 million (2023), compared with a mean of $39.6 million.
  • Biggest five-year swings in Cash & Equivalents: soared 45.5% in 2023 and later tumbled 66.07% in 2025.
  • Xometry's Cash & Equivalents stood at $86.3 million in 2021, then dropped by 23.88% to $65.7 million in 2022, then decreased by 18.64% to $53.4 million in 2023, then plummeted by 58.39% to $22.2 million in 2024, then crashed by 32.55% to $15.0 million in 2025.
  • The last three reported values for Cash & Equivalents were $15.0 million (Q4 2025), $20.8 million (Q3 2025), and $16.8 million (Q2 2025) per Business Quant data.